当前位置: 首页 > 期刊 > 《中西医结合心血管病》 > 2019年第29期
编号:13444791
血清胱抑素C对慢性心力衰竭诊断及疗效评估相关性研究(2)
http://www.100md.com 2019年10月15日 《中西医结合心血管病电子杂志》 2019年第29期
     综上所述,血清Cys-c不仅可作为慢性心力衰竭诊断的标志物之一,而且有助于心力衰竭严重程度及疗效的判断。联合血清Cys-c和血清BNP检测可能有助于提高心衰诊断灵敏度,可以弥补血清BNP的影响因素较多的缺陷。

    参考文献

    [1] Semenov AG,Feygina EE.Standardization of BNP and NT-proBNP immunoassays in light of the diverse and complex nature of circulating BNP-related peptides[J].Adv Clin Chem,2018,85:1-30.

    [2] De Boer RA,Nayor M,deFilippi CR,etal.Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction[J].JAMA Cardiol,2018,3(3):215-224.

    [3] Flores-Blanco PJ,Manzano-Fernández S,Pérez-Calvo JI,et al.Cystatin C-based CKD-EPI equations and Nterminal pro-Btype natriuretic peptide for predicting outcomes in acutely decompensated heart failure[J].Clin Cardiol,2015,38( 2) :106-113.

    [4] 魏丽丽,徐新娟,珠勒皮亚·司马义.血清胱抑素 C 在高血压患者肾功能评价中的应用 [J].中華高血压杂志,2014,22(1):79-80.

    [5] Levin A, Lan JH.Cystatin C and cardiovascular disease: causality, association,and clinical implications of knowing the difference[J].J Am Coll Cardiol,2016,68(9):946-948.

    [6] Carrasco-Sánchez FJ,Pérez-Calvo JI,Morales-Rull JL,etal.Heart failure mortality according to acute variations in N-terminal pro-B type natriuretic peptide and cystatin C levels[J].J Cardiovasc Med( Hagerstown),2014,15(2):115-121

    本文编辑:刘欣悦, http://www.100md.com(李拜红 王晓彦)
上一页1 2